0% found this document useful (0 votes)
74 views24 pages

Menopause

The document discusses menopause and its causes, symptoms, diagnosis, and treatment. It begins by defining key terms like menopause, perimenopause, and climacteric. It then covers the pathophysiology of menopause, symptoms affecting various body systems, risk factors for osteoporosis, and diagnosis. The document concludes by outlining non-hormonal and hormonal treatment options for menopause, including estrogen therapy and combination hormone replacement therapy.

Uploaded by

Meekel Susiku
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
74 views24 pages

Menopause

The document discusses menopause and its causes, symptoms, diagnosis, and treatment. It begins by defining key terms like menopause, perimenopause, and climacteric. It then covers the pathophysiology of menopause, symptoms affecting various body systems, risk factors for osteoporosis, and diagnosis. The document concludes by outlining non-hormonal and hormonal treatment options for menopause, including estrogen therapy and combination hormone replacement therapy.

Uploaded by

Meekel Susiku
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

The Menopause

Dr Chaambwa H
Livingstone Central Hospital
May 2019
Introduction
 The term menopause is derived from Greek Menos (month) and
pausos (cessation). The word means cessation of menstruation.

 Climacteric is period of life when fertility and sexual activity


decline. It is a wide term leading to:

 Pre Menopause

 Peri Menopause

 Post Menopause

Dr Chaambwa, H. OBGY specialist


Definitions
 Perimenopause
 It is 3-5 years period before menopause with increased frequent
irregular anovulatory bleeding followed by episodes of amenorrhea
and intermittent menopausal symptoms.

 Menopause
 The point in time at which menstrual cycles permanently cease. It
is a retrospective diagnosis after 12 months of amenorrhea.

 Mean age – 51 years.

Dr Chaambwa, H. OBGY specialist


Pathophysiology
 The number of primordial follicle decline even before birth but dramatic
just before menopause.
 Loss of follicle → low E2 and inhibin →Increase FSH from about 10 years
before menopause.
 Close to menopause, There will be
 Anovulation → inadequate Luteal phase → decrease progesterone → lead to
BEO and endometrial Hyperplasia
 At menopause dramatic ↓E2 → menstruation ceases and symptoms of
menopause start.
 Main postmenopausal oestrogen is oestrone produced by Peripheral fat
from adrenal androgen.

Dr Chaambwa, H. OBGY specialist


Other causes of menopause

 Drugs eg. GnRH


 Pelvic irradiation
 Chemotherapy
 Surgical removal of ovaries

Dr Chaambwa, H. OBGY specialist


 Premature ovarian failure
 Failure of the ovaries to generate adequate oestrogens
before the age of 40
 Characterised by low E2 and high FSH, and LH with
postmenopausal appearance of ovaries
 Maybe associated with autoimmune disorders, streak
ovaries, iatrogenic etc
 AMH is a measure of ovarian reserve
 Resistant ovary syndrome
 Menopausal biochemistry but normally appearing
ovaries
Dr Chaambwa, H. OBGY specialist
Symptoms of Menopause:
 Hot flushes cutaneous  Psychological changes
vasodilation decreased level of central
 Occurs in 75% of women neurotransmitters
 More severe after surgical  Depression
menopause  Irritability
 Continue for 1 year  Anxiety
 25% continue more than 5 years  Insomnia
 Urinary Symptoms  Lose of concentration
 Urgency
 Frequency
 Nocturia
Dr Chaambwa, H. OBGY specialist
Symptoms of Menopause
 Atrophic Changes  Decrease size of ovaries, become
 Vagina non palpable.

 Vaginitis due to thinning of  Pelvic floor - relaxation →prolapse.


epithelium, pH and ↓ lubrication.  Urinary tract →atrophy →lose of
 Dyspareunia → due to decreased urethral tone →incontinence
vascularity and dryness  Hypertonic Bladder - detrusor
 Decrease size of cervix and mucus instability
with retract of squamocolumnar  Decrease size of breast and benign
(SC) junction into the cysts.
endocervical canal.
 Skin Collagen – ↓ collagen &
 Decrease size of the uterus, thickness → ↓ elasticity of the skin.
shrinking of myoma &
 Reversal of premenstural syndrome
adenomyosis.
Dr Chaambwa, H. OBGY specialist
Symptoms of Menopause
Osteoporosis:
 Bone mass reach peak at the end of their 3rd decade of
life.
 After 40 years bone resorption exceeds bone formation by
0.5% per year.
 This negative balance increase after menopause to a lose
of 5% of bone per year.
 About 50% will have an osteoporotic fracture
 Trabecular bone affected more than cortical bone (distal
radius, proximal femur, vertebrae)
Dr Chaambwa, H. OBGY specialist
Risk factors for Osteoporosis

 Life style
 Gender: more in women
 smoking
 BMI
 caffeine intake
 Race
 alcohol
 highin white women
 increasein protein diet
 moderate in Asian
women  decrease in Calcium and Vit D
intake
 lowest in Black women

 Family History +ve  Steroids


 Exogenous medication
 Cushing Syndrome
Dr Chaambwa, H. OBGY specialist
Diagnosis of Osteoporosis
 DEXA: Dual Energy X-ray Absorptiometry
 For Assessment of bone densimetry to demonstrate if
bone density above or below fracture threshold.

Prevention of Osteoporosis
 Improve lifestyle
 Regular exercise
 Eliminate smoking & alcohol
Dr Chaambwa, H. OBGY specialist
Cardiovascular Disease
 CVD is now the leading cause of death among post menopausal women
 before menopause, risk of heart attack is 1/3 that of man. after
menopause the risk increase and become the same as that of man
Effect of oestrogen before menopause
 increase HDL & decrease LDL.
 decrease atherogenic plague formation by direct action on vascular
endothelium.
After menopause:
 HDL : LDL ratio become closer to male ratio.
 Hence increase in stroke and myocardial infarction risk
Dr Chaambwa, H. OBGY specialist
Urogenital System
 Embryologically female genital tract & lower urinary system
develop in close proximity from primitive urogenital sinus.

 The Urethra and vagina have a high concentration of


oestrogen receptors and there is significant evidence to
support one use of oestrogen in treatment of urogenital
symptoms such as (recurrent UTI, vaginitis and dysparunia).

Dr Chaambwa, H. OBGY specialist


CNS; Dementia

 Prevalence of Dementia as high 50% by age 85 years.

 Alzheimer’s disease account for 60-65% of cases.

 Observation studies –decreased risk of Alzheimer’s by 1/3


among women taking HRT.

Dr Chaambwa, H. OBGY specialist


Diagnosis and Investigations for
menopause
 The Triad of:  No indication to perform
 Hot flushes  bone density
 Amenorrhea  Endometrial Biopsy
 increase FSH > 15iu/L  but any bleeding should
be investigated before
 Before starting treatment: a starting any treatment.
patient should have
 Breast examination
 Mammogram
 Pelvic exam (Pap Smear)
 Weight, Blood pressure
Dr Chaambwa, H. OBGY specialist
Treatment of Menopause
 Non-hormonal treatments
 selective serotonin-reuptake inhibitors (SSRI) and
gabapentin
 The bisphosphonates are the principle class of drug that
inhibit osteoclastic activity
 Calcitonin inhibit osteoclastic activity
 Calcium Supplement & Vit D.
 Raloxifene is selective oestrogen receptors modurator
[SERMs] that bind with a high affinity to oestrogen
receptors. It has some oestrogen like effect e.g. ↑ bone
density, ↓LDL Cholesterol but act as oestrogen antagonist
on endometrium and breast.
Dr Chaambwa, H. OBGY specialist
Treatment of Menopause

 Hormone replacement therapy –HRT


 Oestrogen is the main hormone
 Progestogen
 Testosterone

Dr Chaambwa, H. OBGY specialist


HRT -Oestrogen
 Different oestrogens are used in HRT

 Oestradiol (transdermal, gel, implant)

 Oestradiol valerate (oral, gel)

 Conjugated equine oestrogens (oral, gel)

 Oestrone sulphate Oestriol (vaginal only)

Dr Chaambwa, H. OBGY specialist


HRT -Progestogens

 Different progestogens used in


 In women with uterus, HRT
progestin is added to
prevent endometrial  Norethisterone (transdermal)
hyperplasia  Levonorgestrel (transdermal,
 Theses can be: intrauterine)
 Cyclically  Dydrogesterone

 Continuously  Medroxyprogesterone acetate


 Cyproterone acetate
 Drospirenone Progesterone
Dr Chaambwa, H. OBGY specialist
 Micronized progesterone
 Testosterone
 women who undergo a surgical or chemoradiation-
induced menopause

 Tibolone

 this has oestrogenic, progestogenic, and


androgenic activity

Dr Chaambwa, H. OBGY specialist


Benefits of HRT
 Vasomotor symptoms subsides

 Vagina-↑ vaginal thickness of epithelium →↓ dyspareunia &


vaginitis.

 Urinary tract – enhancing normal bladder function.

 Osteoporosis – decrease fractures by more than 50%

 Reduced risk of CVA and CHD

 Colon Cancer decrease up to 50%


Dr Chaambwa, H. OBGY specialist
Contraindication to HRT

 Absolute  Relative
 Present or suspected  Presence of uterine
pregnancy fibroids
 Suspicion of breast  Past history of benign
cancer breast disease
 Suspicion of
 Unconfirmed VTE
endometrial, cancer
 Chronic stable liver
 Acute active liver
disease disease
 Uncontrolled  Migraine
hypertension  The presence of any
 Confirmed VTE of the conditions
Dr Chaambwa, H. OBGY specialist
Post Menopausal Bleeding
 Vaginal bleeding occurs after 12months of Amenorrhea in middle age
women who are not receiving replacement therapy.

 Causes
 Atrophic Endometritis

 Endometrial Polyp

 Endometrial Hyperplasia

 Endometrial Cancer

Dr Chaambwa, H. OBGY specialist


Dr Chaambwa, H. OBGY specialist

You might also like